Draft genome data analysis and pathogenicity profiling of Staphylococcus aureus strain IHS3A with antibiotic resistance genes isolated from a hospital in Jordan
Related Experiment Video
Updated: Feb 4, 2026

Methodology for the Study of Horizontal Gene Transfer in Staphylococcus aureus
Published on: March 10, 2017
Saqr Abushattal1, Sulaiman M Alnaimat1, Nidal Odat2
1Department of Medical Analysis, Faculty of Allied Medical Sciences, Al-Hussein Bin Talal University, Ma'an, Jordan.
Abstract:
This dataset provides a comprehensive genomic and pathogenicity profiling of Staphylococcus aureus strain IHS3A, a methicillin-resistant (MRSA) clinical isolate obtained from a healthcare worker in a teaching hospital in Jordan, Middle East. Whole genome sequencing was performed using the Illumina NextSeq 2000 platform, followed by high-quality de novo assembly using SPAdes. The genome spans 2821,373 bp across 90 contigs, with a GC content of 32.78%, and demonstrates high-quality metrics, including 99.67% completeness and minimal contamination (0.08%). The genome analysis identified 2611 predicted protein-coding sequences. Multilocus sequence typing (MLST) assigned the isolate to ST10647, SCCmec typing revealed type IVc (2B), and spa typing identified t131. The dataset includes comprehensive annotations of key antimicrobial resistance genes, such as mecA (methicillin resistance), blaZ (penicillin resistance), and lmrS (macrolide efflux), as well as virulence factors related to adherence (e.g., atl, clfA), immune evasion (e.g., scn, adsA), secretion systems (e.g., esaA, esaB), and toxins (e.g., hla, lukF-PV, tsst). Secondary metabolite biosynthetic gene clusters, such as staphyloferrin B and staphylopine, were identified. The genome also encodes a diverse carbohydrate-active enzyme (CAZyme) profile. These genomic data are valuable for further research on MRSA evolution, resistance mechanisms, and virulence factors in Jordan and the Middle East. The genome data have been deposited in the NCBI database under the accession number JBPPGA000000000, with a direct URL to data: https://www.ncbi.nlm.nih.gov/nuccore/JBPPGA000000000.1. Bioproject: PRJNA1283614, Biosample: SAMN49700843.
Insights
This study presents the whole genome sequencing of methicillin-resistant Staphylococcus aureus (MRSA) strain IHS3A from Jordan. It details its genetic makeup, including antimicrobial resistance and virulence genes, offering insights into MRSA in the Middle East.
Area of Science:
- Microbiology
- Genomics
- Infectious Diseases
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) is a significant global health threat.
- Understanding the genomic basis of MRSA isolates is crucial for developing effective control strategies.
- Clinical isolates from the Middle East are underrepresented in genomic databases.
Purpose of the Study:
- To perform comprehensive genomic and pathogenicity profiling of a clinical MRSA isolate (IHS3A) from Jordan.
- To identify key antimicrobial resistance and virulence factors within the isolate.
- To contribute valuable genomic data for MRSA research in the Middle East.
Main Methods:
- Whole genome sequencing using Illumina NextSeq 2000.
- High-quality de novo genome assembly with SPAdes.
- Bioinformatic analysis including MLST, SCCmec, spa typing, and annotation of resistance/virulence genes.
Main Results:
- The MRSA strain IHS3A genome is 2.82 Mbp with 2611 predicted protein-coding sequences.
- Identified as ST10647, SCCmec type IVc (2B), and spa type t131.
- Annotated key genes for methicillin (mecA), penicillin (blaZ), macrolide resistance (lmrS), adherence (atl, clfA), immune evasion (scn, adsA), and toxins (hla, lukF-PV, tsst).
Conclusions:
- The genomic data provide a detailed profile of an MRSA clinical isolate from Jordan.
- The identified resistance and virulence factors offer insights into MRSA pathogenicity and adaptation.
- This dataset serves as a valuable resource for studying MRSA evolution and epidemiology in the Middle East.
More Related Videos
Related Concept Videos
Genome Size and the Evolution of New Genes
Genome Size and the Evolution of New Genes
Development of Antibiotic Resistance
Antibiotic Selection
Hospitals-II
Nurses that work in...
Hospitals-I

